InspireMD Inc (NSPR) USD0.0001
Sell:$2.47Buy:$3.00
$0.01
(0.38%)
- This stock can be held in a
Stocks and Shares ISA$0.01
(0.38%)$0.01
(0.38%)Company Information
About this company
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Key people
Key facts
- EPICNSPR
- LocationIsrael
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS45779A8466
- Market cap$79.35m
- Employees85
- Shares in issue30.64m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.